Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease

Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease

US Patent 10112935 · Granted Oct 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alkynyl quinazoline compounds2025
Macrocyclic derivative of pyrazol[3,4-d]pyrimidin-3-one, pharmaceutical composit2022
Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use a2021
Targeted therapeutics2020
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compo2020
Benzazepine derivative, preparation method, pharmaceutical composition and use t2020
Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use a2020
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-ass2020
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-ass2020
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-ass2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020